Guggenheim Maintains Buy on CryoPort, Raises Price Target to $19

Guggenheim analyst Subbu Nambi has maintained a Buy rating on CryoPort (NASDAQ: CYRX) and raised the price target from $16 to $19. This adjustment reflects a positive outlook for the company's stock performance.